Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Ennature Bio Pharma lists on NSE and BSE, targets branded nutraceuticals growth

The portfolio includes thiocolchicoside, colchicine, nicotine, and vinpocetine, serving over 150 customers across 26 countries, with exports at 54% of segment revenue

Ennature Bio Pharma lists on NSE and BSE, targets branded nutraceuticals growth

We haven't written up this one. Hindu BusinessLine has the full story — the link below goes straight to it.

Read the original at thehindubusinessline.com →

More in Health & Medicine

More from Wednesday 4 November →